OK Biotech Co., Ltd.

TWSE:4155.TW

25.4 (TWD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 8.026175.59446.14151.656143.378201.595163.194132.57814479.077155.83996.67872.3437.73649.7
Depreciation & Amortization 75.54767.88255.88250.07741.55430.28823.42225.53629.3829.08721.76312.0038.5226.0062.696
Deferred Income Tax -32.1370-19.019-13.135-44.001-6.069-40.388-62.945-3.398-6.02-22.3290.2140.264-0.690
Stock Based Compensation 3.2603.3983.7325.4046.23810.19910.0427.7948.5444.576.2143.9820.1630
Change In Working Capital -46.186-56.75-66.685-43.346-104.836-98.525-59.097158.178109.768-141.765-122.905-37.7193.196-66.822-46.468
Accounts Receivables -78.911-71.86-86.72-29.001-29.389-53.15413.783-5.816-7.989-18.325-46.547-60.658000
Inventory 28.9-47.31-26.5698.805-87.996-70.683-15.84394.503-10.10521.059-141-5.769-44.197-39.391-24.776
Accounts Payables -45.5066.09632.853-11.42720.4947.231-36.26156.02486.526000000
Other Working Capital 49.33156.32413.751-11.723-7.941-27.842-43.25463.675119.873-162.82418.095-31.9547.393-27.431-21.692
Other Non Cash Items -5.57753.82.18-1.2843.678-4.7775.438-2.6651.891-2.75750.1471.7834.8134.0921.022
Operating Cash Flow 2.933240.52621.896147.745.177128.75102.768260.724289.435-33.83487.08579.17393.117-19.5156.95
Investing Activities:
Investments In Property Plant And Equipment -437.079-294.241-86.463-79.79-77.955-28.362-88.038-56.993-86.463-5.685-202.909-88.533-36.995-68.152-35.062
Acquisitions Net 12.1085.093.109-301.807-0.707-0.90.0380.010-458.9160000
Purchases Of Investments -12.108-5-91.026-19.739-16-5.557-50-0.174-45-0.183-14.808000
Sales Maturities Of Investments 66.6-5.09-3.10900.1190.816-0.16200014.8080000
Other Investing Activites 12.0975.0113.0292.5666.535-28.371-2.452-10.6136.381-4.571-4.099-0.425-0.353-0.629-1.618
Investing Cash Flow -358.382-294.23-174.46-126.963-85.494-62.181-96.552-67.606-80.082-55.256-651.299-103.766-37.348-68.781-36.68
Financing Activities:
Debt Repayment -12.598-1,890.972-1,279.656-2,634.178-687.823-1,279.972-947.048-267.05-248.471-1,656.837-1,455.910000
Common Stock Issued 270027.2424035.7341,132.591227.233.1196.217160.1239.21666.445070.830
Common Stock Repurchased 0002,553.842-5.734-39.59100-22.391000000
Dividends Paid -144.64-94.934-131.85-112.142-166.387-111.343-100.434-100.183-10.607-15.958-10.144-30.112-8.56-4.730
Other Financing Activities 239.3012,036.1751,569.9585.2931,039.282-39.5911,105.41260.001751,547.2721,922.403105.62519.9030
Financing Cash Flow 82.06350.269185.694215.815185.072-337.906285.158-104.113-200.25234.6465.565141.93316.4485.97330
Other Information:
Effect Of Forex Changes On Cash 000-2.143.1330.0260.018-0.424-0.1660.41700000
Net Change In Cash -273.386-3.43533.13234.412147.888-271.311291.39288.5818.935-54.073-98.649117.3472.209-2.3230.27
Cash At End Of Period 323.033596.419599.854566.724332.312184.424455.735164.34375.76266.827120.9219.549102.2093032.323